-
EP4326330
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4326330
| EP4326330 - GLUCAGON LIKE PEPTIDE COMPOUNDS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 26.01.2024 Database last updated on 26.06.2024 | |
| Former | The international publication has been made Status updated on 28.10.2022 | ||
| Former | unknown Status updated on 07.05.2022 | Most recent event Tooltip | 01.06.2024 | Amendment by applicant | Applicant(s) | For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH | [2024/09] | Inventor(s) | 01 /
BEAULIEU, Valerie Cambridge, Massachusetts 02139 / US | 02 /
GALYAN, Keith Cambridge, Massachusetts 02139 / US | 03 /
GAO, Jinhai Cambridge, Massachusetts 02139 / US | 04 /
GINSBURG-MORAFF, Carol Cambridge, Massachusetts 02139 / US | 05 /
JAIN, Pankaj Cambridge, Massachusetts 02139 / US | 06 /
MARCINKEVICIENE, Jovita Cambridge, Massachusetts 02139 / US | 07 /
MICHAEL, Walter Cambridge, Massachusetts 02139 / US | 08 /
MOGI, Muneto Cambridge, Massachusetts 02139 / US | 09 /
MARRO, Martin Cambridge, Massachusetts 02139 / US | 10 /
PATEL, Sejal Cambridge, Massachusetts 02139 / US | 11 /
PLUMMER, Scott Cambridge, Massachusetts 02139 / US | 12 /
SINGH, Alok Cambridge, Massachusetts 02139 / US | 13 /
USERA, Aimee Cambridge, Massachusetts 02139 / US | [2024/09] | Representative(s) | Amodio, Eliana Lucia Novartis Pharma AG Patent Department Lichtstrasse 35 4056 Basel / CH | [2024/09] | Application number, filing date | 22719363.8 | 20.04.2022 | [2024/09] | WO2022IB53698 | Priority number, date | EP20210169757 | 21.04.2021 Original published format: EP 21169757 | [2024/09] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022224164 | Date: | 27.10.2022 | Language: | EN | [2022/43] | Type: | A1 Application with search report | No.: | EP4326330 | Date: | 28.02.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 27.10.2022 takes the place of the publication of the European patent application. | [2024/09] | Search report(s) | International search report - published on: | EP | 27.10.2022 | Classification | IPC: | A61K47/54, C07K14/605, A61P5/48 | [2024/09] | CPC: |
A61P5/48 (EP,IL);
C07K14/605 (EP,IL,KR);
A61K38/26 (KR);
A61K47/542 (EP,IL,KR);
A61P13/12 (KR);
A61P25/00 (KR);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/09] | Extension states | BA | 21.11.2023 | ME | Not yet paid | Validation states | KH | Not yet paid | MA | 21.11.2023 | MD | Not yet paid | TN | 21.11.2023 | Title | German: | GLUCAGONÄHNLICHE PEPTIDVERBINDUNGEN | [2024/09] | English: | GLUCAGON LIKE PEPTIDE COMPOUNDS | [2024/09] | French: | COMPOSÉS PEPTIDIQUES DE TYPE GLUCAGON | [2024/09] | Entry into regional phase | 21.11.2023 | National basic fee paid | 21.11.2023 | Designation fee(s) paid | 21.11.2023 | Examination fee paid | Examination procedure | 21.11.2023 | Examination requested [2024/09] | 21.11.2023 | Date on which the examining division has become responsible | 30.05.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 22.03.2024 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [YD]WO2006097537 (NOVO NORDISK AS [DK], et al); | [XDY]WO2015200078 (NOVARTIS AG [CH], et al); | [Y]WO2016083499 (NOVO NORDISK AS [DK]); | [XY]WO2016116842 (NOVARTIS AG [CH], et al) | by applicant | WO2006097537 | WO2015200078 |